APP and Alzheimer disease: Our preliminary studies have demonstrated that CEBP/β in neurons can exacerbate the pathological progression of AD by cleaving APP and tau through the activation of asparagine endopeptidase (AEP, also known as δ-secretase) [122,187,188].